Publications by authors named "Scott D Lee"

Claim this Profile
L
Long-Term Safety of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis: An Integrated 2-Year Safety Analysis.
Scott D Lee, Adam C Ehrlich, Paola Pellanda, Christopher Kaiser, Kristin Todd

Am J Gastroenterol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ustekinumab Intravenous Reinduction after Secondary Loss of Response in Patients with Crohn's Disease.
Stefan Schreiber, Scott D Lee, C Janneke van der Woude, Ignacio Marín-Jiménez, Douglas C Wolf

Inflamm Bowel Dis· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Three-Year Efficacy and Safety of Mirikizumab Following 152 Weeks of Continuous Treatment for Ulcerative Colitis: Results From the LUCENT-3 Open-Label Extension Study.
Bruce E Sands, Geert D'Haens, David B Clemow, Peter M Irving, Jordan T Johns, Scott D Lee

Inflamm Bowel Dis· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Upadacitinib Maintenance Therapy in Crohn's Disease: Final Results From the Randomized Phase 3 U-ENDURE Study.
Remo Panaccione, Miguel Regueiro, Scott D Lee, Raja Atreya, Gitte Pedersen

Clin Gastroenterol Hepatol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Upadacitinib Results in Endoscopic Remission in Patients With Inflammatory Bowel Disease and Prior Tofacitinib Failure.
Scott David Lee, Kendra J Kamp, Jeffrey Jacobs, Jason Harper, Mitra Barahimi

J Clin Gastroenterol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mirikizumab Improves Quality of Life and Work Productivity in Patients with Moderately to Severely Active Crohn's Disease: Results from the Phase 3 VIVID-1 Study.
Scott D Lee, Severine Vermeire, Ryan Ungaro, Aisha Vadhariya, Frederick Durand

Am J Gastroenterol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discordance between endoscopic and histopathologic assessment in ileal Crohn's disease.
Scott D Lee, Brian Mau, Cody J Avalos, Kindra D Clark-Snustad, Kendra J Kamp

World J Gastrointest Endosc· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Certolizumab Pegol Treatment in Patients With Crohn's Disease: Final Safety Data From the SECURE Registry.
Gary R Lichtenstein, Scott D Lee, Brian G Feagan, Edward V Loftus, Samson Ng

Crohns Colitis 360· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mycophenolate Mofetil Appears Effective for the Treatment of Patients With Refractory Crohn's Disease.
Sam Rosenfeld, Kindra Clark-Snustad, Kendra J Kamp, Jeffrey Jacobs, Mitra Barahimi, Scott David Lee

Crohns Colitis 360· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Patterns and Economic Burden Associated With Treatment Failure With Advanced Therapies in Patients With Moderate-to-Severe Ulcerative Colitis.
Scott D Lee, Keith A Betts, Ella Xiaoyan Du, Xiaoyu Nie, Komal Gupte-Singh

Crohns Colitis 360· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolution of Symptoms After Ustekinumab Induction Therapy in Patients With Crohn's Disease.
Jean-Frédéric Colombel, Bruce E Sands, Christopher Gasink, Benjamin Yeager, Omoniyi J Adedokun, Scott D Lee

Clin Gastroenterol Hepatol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of Bowel Urgency With Quality-of-Life Measures in Patients With Moderately-to-Severely Active Ulcerative Colitis: Results From Phase 3 LUCENT-1 (Induction) and LUCENT-2 (Maintenance) Studies.
Millie D Long, Stefan Schreiber, Toshifumi Hibi, Theresa Hunter Gibble, Deborah A Fisher, Scott D Lee

Crohns Colitis 360· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship of Sleep Health and Endoscopic Disease Activity in Inflammatory Bowel Disease: Endoscopic Disease Activity and Sleep.
Kendra J Kamp, Linda Yoo, Kindra Clark-Snustad, Samantha Winders, Robert Burr, Scott D Lee

Gastroenterol Nurs· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of risankizumab on health-related quality of life in patients with Crohn's disease: results from phase 3 MOTIVATE, ADVANCE and FORTIFY clinical trials.
Laurent Peyrin-Biroulet, Subrata Ghosh, Scott D Lee, Wan-Ju Lee, Jenny Griffith

Aliment Pharmacol Ther· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tofacitinib as a maintenance therapy in patients with ulcerative colitis stratified by OCTAVE Sustain baseline Mayo endoscopic subscore.
Scott D Lee, Jessica R Allegretti, Flavio Steinwurz, Susan B Connelly, Nervin Lawendy

BMC Gastroenterol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tofacitinib Appears Well Tolerated and Effective for the Treatment of Patients with Refractory Crohn's Disease.
Scott David Lee, Anand Singla, Jason Harper, Mitra Barahimi, Jeffrey Jacobs

Dig Dis Sci· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Safety and Efficacy of the Anti-Mucosal Addressin Cell Adhesion Molecule-1 Monoclonal Antibody Ontamalimab (SHP647) for the Treatment of Crohn's Disease: The OPERA II Study.
Geert R D'Haens, Walter Reinisch, Scott D Lee, Dino Tarabar, Edouard Louis

Inflamm Bowel Dis· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Bowel Urgency on Quality of Life and Clinical Outcomes in Patients With Ulcerative Colitis.
Marla C Dubinsky, Remo Panaccione, James D Lewis, Bruce E Sands, Toshifumi Hibi, Scott D Lee

Crohns Colitis 360· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case Series: Re-induction of Intravenous, Weight-Based Ustekinumab Is Well Tolerated in Patients With Moderate-Severe Crohn's Disease.
Scott David Lee, Kendra Kamp, Kindra Dawn Clark-Snustad

Crohns Colitis 360· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Efficacy of Tofacitinib in Combination With Biologic Therapy for Refractory Crohn's Disease.
Scott David Lee, Anand Singla, Jason Harper, Mitra Barahimi, Jeffrey Jacobs

Inflamm Bowel Dis· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic Review With Meta-analysis: Safety and Effectiveness of Combining Biologics and Small Molecules in Inflammatory Bowel Disease.
Quazim A Alayo, Marc Fenster, Osama Altayar, Kerri L Glassner, Ernesto Llano, Scott D Lee

Crohns Colitis 360· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic Drug Monitoring for Current and Investigational Inflammatory Bowel Disease Treatments.
Scott D Lee, Raina Shivashankar, Daniel Quirk, Haiying Zhang, Jean-Baptiste Telliez

J Clin Gastroenterol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health Maintenance in Ulcerative Colitis.
Scott D Lee

Gastroenterol Clin North Am· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Etrasimod in a Phase 2 Randomized Trial of Patients With Ulcerative Colitis.
William J Sandborn, Laurent Peyrin-Biroulet, Jinkun Zhang, Michael Chiorean, Séverine Vermeire, Scott D Lee

Gastroenterology· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Infliximab in Crohn's Disease Patients with Prior Primary-Nonresponse to Tumor Necrosis Factor Antagonists.
Kindra Dawn Clark-Snustad, Anand Singla, Scott David Lee

Dig Dis Sci· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis